Implex Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $108M

Implex General Information

Description

Provider of orthopedic implant products. The company provides hedrocel biomaterial, an open cell, tantalum metal structure that approximates the appearance of human cancellous bone.

Contact Information

Website
www.implex.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 80 Commerce Drive
  • Allendale, NJ 07401
  • United States
+1 (201)
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Acquirer
Zimmer Biomet Holdings
Corporate Office
  • 80 Commerce Drive
  • Allendale, NJ 07401
  • United States
+1 (201)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Implex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 23-Apr-2004 $108M Completed Generating Revenue
1. Early Stage VC 01-Feb-1995 Completed Generating Revenue
To view Implex’s complete valuation and funding history, request access »

Implex Patents

Implex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-1996039974-A1 Femoral head core channel filling prosthesis Inactive 07-Jun-1995
AU-3214295-A Acetabular cup, method and tool for installing the same Inactive 04-Aug-1994
WO-1996003931-A1 Acetabular cup, method and tool for installing the same Inactive 04-Aug-1994
WO-1995020370-A1 Vertebral body prosthetic implant Inactive 26-Jan-1994
AU-1604295-A Vertebral body prosthetic implant ir Inactive 26-Jan-1994 A61L27/047
To view Implex’s complete patent history, request access »

Implex Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biomet Corporation Minority
C. R. Bard Corporation Minority
InnoCal Venture Capital Venture Capital Minority
MVP Capital Partners PE/Buyout Minority
Oracle Capital Partners PE/Buyout Minority
To view Implex’s complete investors history, request access »

Implex Acquisitions (1)

Implex’s most recent deal was a Merger/Acquisition with Main Avenue Pharmacy for . The deal was made on 30-Jun-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Main Avenue Pharmacy 30-Jun-2014 Merger/Acquisition Specialty Retail
To view Implex’s complete acquisitions history, request access »

Implex FAQs

  • When was Implex founded?

    Implex was founded in 1991.

  • Where is Implex headquartered?

    Implex is headquartered in Allendale, NJ.

  • What industry is Implex in?

    Implex’s primary industry is Biotechnology.

  • Is Implex a private or public company?

    Implex is a Private company.

  • What is the current valuation of Implex?

    The current valuation of Implex is .

  • What is Implex’s current revenue?

    The current revenue for Implex is .

  • Who are Implex’s investors?

    Biomet, C. R. Bard, InnoCal Venture Capital, MVP Capital Partners, and Oracle Capital Partners have invested in Implex.

  • When was Implex acquired?

    Implex was acquired on 23-Apr-2004.

  • Who acquired Implex?

    Implex was acquired by Zimmer Biomet Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process